4-chloro-alpha,alpha,alpha-trifluoro-3-nitrotoluene: RN given refers to cpd with specified locants; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| ID Source | ID |
|---|---|
| PubMed CID | 8462 |
| CHEMBL ID | 1723690 |
| SCHEMBL ID | 140068 |
| MeSH ID | M0089494 |
| Synonym |
|---|
| benzene, 1-chloro-2-nitro-4-(trifluoromethyl)- |
| 3-nitro-4-chlorobenzotrifluoride |
| 4-chloro-3-nitrobenzylidyne fluoride |
| 2-chloro-5-(trifluoromethyl)nitrobenzene |
| 4-chloro-3-nitrobenzotrifluoride |
| nsc8760 |
| 121-17-5 |
| toluene,.alpha.,.alpha.-trifluoro-3-nitro- |
| 3-nitro-4-chlorotrifluoromethylbenzene |
| 4-chloro-3-nitro-1-(trifluoromethyl)benzene |
| 2-nitro-4-trifluoromethylchlorobenzene |
| 4-chloro-.alpha.,.alpha.-trifluoro-3-nitrotoluene |
| nsc-8760 |
| toluene, 4-chloro-.alpha.,.alpha.,.alpha.-trifluoro-3-nitro- |
| 4-chloro-3-nitro-a,a,a-trifluorotoluene |
| NCGC00091167-01 |
| toluene, 4-chloro-alpha,alpha,alpha-trifluoro-3-nitro- |
| 2-chloro-5-trifluoromethylnitrobenzene |
| toluene, 4-chloro-3-nitro-alpha,alpha,alpha-trifluoro- |
| un2307 |
| hsdb 4257 |
| nsc 8760 |
| 4-chloro-alpha,alpha,alpha-trifluoro-3-nitrotoluene |
| benzotrifluoride, 4-chloro-3-nitro- |
| 3-nitro-4-chloro-alpha,alpha,alpha-trifluorotoluene |
| brn 0523986 |
| 4-chloro-3-nitro-alpha,alpha,alpha-trifluorotoluene |
| einecs 204-451-6 |
| ai3-26184 |
| ccris 2817 |
| 4-chloro-3-nitrobenzotrifluoride, 97% |
| 1-chloro-2-nitro-4-(trifluoromethyl)benzene |
| AC-10902 |
| cmnt |
| MLS002454377 |
| smr001371997 |
| AKOS000120171 |
| A2547 |
| NCGC00091167-02 |
| HMS3039H03 |
| NCGC00257234-01 |
| cas-121-17-5 |
| tox21_303339 |
| dtxsid2024799 , |
| dtxcid104799 |
| tox21_201833 |
| NCGC00259382-01 |
| 82344306tn , |
| 4-05-00-00857 (beilstein handbook reference) |
| 3-nitro-4-chlorobenzotrifluoride [un2307] [poison] |
| ec 204-451-6 |
| unii-82344306tn |
| FT-0618088 |
| FT-0618087 |
| AM20060283 |
| 4-chloro-3-nitrobenzotrifluoride [hsdb] |
| 4-chloro-3-nitro-.alpha.,.alpha.,.alpha.-trifluorotoluene |
| 4-trifluoromethyl-2-nitrochlorobenzene |
| 6-chloro-3-(trifluoromethyl)nitrobenzene |
| STL264265 |
| SCHEMBL140068 |
| 4-chloro- 3-nitro-benzotrifluoride |
| 2-nitro-4-(trifluoromethyl)chlorobenzene |
| 1-chloro-2-nitro-4-trifluoromethylbenzene |
| 2-chloro-5-trifluoromethyl-nitrobenzene |
| 4-chloro-3-nitro-1-trifluoromethyl-benzene |
| 2-nitro-4-trifluoromethyl-1-chlorobenzene |
| 1-chloro-2-nitro-4-trifluoromethyl-benzene |
| 2-chloro-1-nitro-5-trifluoromethylbenzene |
| 4-chloro-3-nitro-benzotrifluoride |
| 4-chloro-3-nitrotrifluoromethylbenzene |
| 4-chloro-3-nitrobenzo-trifluoride |
| 4-chloro-3-nitro-1-trifluoromethylbenzene |
| toluene, 4-chloro-3-nitro-.alpha.,.alpha.,.alpha.-trifluoro- |
| 3-nitro-4-(chloro)trifluoromethylbenzene |
| 1-chloro-2-nitro-4-(trifluoromethyl)benzene # |
| 3-nitro-4-chloro-.alpha.,.alpha.,.alpha.-trifluorotoluene |
| 4-chloro-.alpha.,.alpha.,.alpha.-trifluoro-3-nitrotoluene |
| un 2307 |
| 1-chloro-4-trifluoromethyl-2-nitrobenzene |
| (3-nitro-4-chlorophenyl)trifluoromethane |
| CHEMBL1723690 |
| W-108461 |
| mfcd00007084 |
| F0001-0340 |
| CS-W001073 |
| 4-chloro-1-trifluoromethyl-3-nitro-benzene |
| PS-10522 |
| E78890 |
| Q27269296 |
| PD013788 |
| EN300-17932 |
| Z57117625 |
| Protein | Taxonomy | Measurement | Average (µ) | Min (ref.) | Avg (ref.) | Max (ref.) | Bioassay(s) |
|---|---|---|---|---|---|---|---|
| estrogen-related nuclear receptor alpha | Homo sapiens (human) | Potency | 0.5448 | 0.0015 | 30.6073 | 15,848.9004 | AID1224841 |
| estrogen nuclear receptor alpha | Homo sapiens (human) | Potency | 17.3760 | 0.0002 | 29.3054 | 16,493.5996 | AID743069 |
| aryl hydrocarbon receptor | Homo sapiens (human) | Potency | 69.9870 | 0.0007 | 23.0674 | 1,258.9301 | AID743085 |
| thyroid hormone receptor beta isoform 2 | Rattus norvegicus (Norway rat) | Potency | 55.5927 | 0.0003 | 23.4451 | 159.6830 | AID743065 |
| geminin | Homo sapiens (human) | Potency | 1.8356 | 0.0046 | 11.3741 | 33.4983 | AID624296 |
| histone acetyltransferase KAT2A isoform 1 | Homo sapiens (human) | Potency | 31.6228 | 0.2512 | 15.8432 | 39.8107 | AID504327 |
| Cellular tumor antigen p53 | Homo sapiens (human) | Potency | 19.3312 | 0.0023 | 19.5956 | 74.0614 | AID651631 |
| [prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] | |||||||
| Assay ID | Title | Year | Journal | Article |
|---|---|---|---|---|
| AID588499 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set | 2010 | Current protocols in cytometry, Oct, Volume: Chapter 13 | Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening. |
| AID588499 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set | 2006 | Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5 | Microsphere-based protease assays and screening application for lethal factor and factor Xa. |
| AID588499 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set | 2010 | Assay and drug development technologies, Feb, Volume: 8, Issue:1 | High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors. |
| AID651635 | Viability Counterscreen for Primary qHTS for Inhibitors of ATXN expression | |||
| AID504812 | Inverse Agonists of the Thyroid Stimulating Hormone Receptor: HTS campaign | 2010 | Endocrinology, Jul, Volume: 151, Issue:7 | A small molecule inverse agonist for the human thyroid-stimulating hormone receptor. |
| AID588497 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set | 2010 | Current protocols in cytometry, Oct, Volume: Chapter 13 | Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening. |
| AID588497 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set | 2006 | Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5 | Microsphere-based protease assays and screening application for lethal factor and factor Xa. |
| AID588497 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set | 2010 | Assay and drug development technologies, Feb, Volume: 8, Issue:1 | High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors. |
| AID588501 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set | 2010 | Current protocols in cytometry, Oct, Volume: Chapter 13 | Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening. |
| AID588501 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set | 2006 | Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5 | Microsphere-based protease assays and screening application for lethal factor and factor Xa. |
| AID588501 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set | 2010 | Assay and drug development technologies, Feb, Volume: 8, Issue:1 | High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors. |
| AID1745845 | Primary qHTS for Inhibitors of ATXN expression | |||
| AID504810 | Antagonists of the Thyroid Stimulating Hormone Receptor: HTS campaign | 2010 | Endocrinology, Jul, Volume: 151, Issue:7 | A small molecule inverse agonist for the human thyroid-stimulating hormone receptor. |
| [information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||||
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 3 (37.50) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 3 (37.50) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (11.83) All Compounds (24.57) |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 1 (11.11%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 8 (88.89%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||